Inogen Inc. (INGN), having delivered strong top-line results for the second quarter, has raised its guidance for the full year of 2025.
This medical technology company offers innovative respiratory products for use in the home care setting. It manufactures and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions, and the Simeox product for airway clearance treatment. Inogen's proprietary Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week, with a battery, and can be plugged into an outlet when at home, in a car, or a public place with outlets available.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.